David L. Ramírez

Also affiliated with The University of Texas MD Anderson Cancer Center, University of Concepción, Universidad de Las Américas

Biochemistry, Genetics and Molecular BiologyComputer ScienceMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer”.

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00722-1

N/A

0.550DataRank · unranked

18 citations

Nicole M. Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang, David L. Ramírez +6 more

Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.09.663851

N/A

0.165DataRank · unranked

2 citations

Gabriel M. Pagnotti, Joseph L. Kidd, David L. Ramírez, Trupti Trivedi, Leah Gandee +13 more

Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.10.030

N/A

0DataRank · unranked

21 citations

Alexander D. Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker +19 more

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer

Investigational New Drugs(2020)10.1007/s10637-020-00995-2

N/A

0DataRank · unranked

28 citations

Gaiane M. Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth E. Ravenberg, Jason B. White +14 more

Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterations

ESMO Open(2025)10.1016/j.esmoop.2025.105895

N/A

0DataRank · unranked

0 citations

Chieh Tseng, Hai T. Tran, Siqing Fu, Ecaterina E. Dumbrava, Timothy A. Yap +8 more

Constitutive sodium permeability in a C. elegans two-pore domain potassium channel

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.22.576648

N/A

0DataRank · unranked

0 citations

Ismail Ben Soussia, Philippe Tardy, Denise S. Walker, Carlo Pena-Varas, David L. Ramírez +9 more

Phase I safety and efficacy study of autophagy inhibition with hydroxychloroquine to augment the antiproliferative and biological effects of preoperative palbociclib plus letrozole for estrogen receptor-positive, HER2-negative metastatic breast cancer (MBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1067

N/A

0DataRank · unranked

3 citations

Danielle Kwiatkowski, Senthil Damodaran, Nicole M. Kettner, David L. Ramírez, Dan S. Gombos +5 more